Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictors of response to intra-arterial vasodilatory therapy of non-occlusive mesenteric ischemia in patients with severe shock: results from a prospective observational study. | Crit Care | 2022 | 35379286 | PubTator, text mining | PubMed |
| Maternal Sodium p-Perfluorous Nonenoxybenzene Sulfonate Exposure Disturbed Lipid Metabolism and Induced an Imbalance in Tyrosine Metabolism in the F1 Generation of Mice. | Chem Res Toxicol | 2022 | 35377151 | PubTator, text mining | PubMed |
| Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling. | J Biol Chem | 2022 | 35367211 | PubTator, text mining | PubMed |
| Clinical and translational values of spatial transcriptomics. | Signal Transduct Target Ther | 2022 | 35365599 | PubTator, text mining | PubMed |
| Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury. | BMC Nephrol | 2022 | 35361160 | PubTator, text mining | PubMed |
| Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes. | Ther Adv Endocrinol Metab | 2022 | 35355954 | PubTator, text mining | PubMed |
| Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database. | Front Pharmacol | 2022 | 35355731 | PubTator, text mining | PubMed |
| Alterations in common marmoset gut microbiome associated with duodenal strictures. | Sci Rep | 2022 | 35347206 | PubTator, text mining | PubMed |
| Point-of-Care (POC) Urinary L-Type Fatty Acid-Binding Protein (u-LFABP) Use in Critically Ill, Very Preterm Neonates. | Int J Nephrol | 2022 | 35345834 | PubTator, text mining | PubMed |
| Integrated single-cell sequencing and histopathological analyses reveal diverse injury and repair responses in a participant with acute kidney injury: a clinical-molecular-pathologic correlation. | Kidney Int | 2022 | 35339536 | PubTator, text mining | PubMed |
| Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. | Toxicol Appl Pharmacol | 2022 | 35337807 | PubTator, text mining | PubMed |
| Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus. | Viruses | 2022 | 35337059 | PubTator, text mining | PubMed |
| Acute Kidney Injury: Biomarker-Guided Diagnosis and Management. | Medicina (Kaunas) | 2022 | 35334515 | PubTator, text mining | PubMed |
| Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes Registry. | Diabetes Res Clin Pract | 2022 | 35331809 | PubTator, text mining | PubMed |
| Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells. | BMC Cancer | 2022 | 35331184 | PubTator, text mining | PubMed |
| Bioinformatics Analyses Identify the Therapeutic Potential of ST8SIA6 for Colon Cancer. | J Pers Med | 2022 | 35330401 | PubTator, text mining | PubMed |
| Urinary Activin A: A Novel Biomarker for Human Acute Kidney Injury. | Diagnostics (Basel) | 2022 | 35328214 | PubTator, text mining | PubMed |
| Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease. | Biomolecules | 2022 | 35327540 | PubTator, text mining | PubMed |
| Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease. | Biomedicines | 2022 | 35327498 | PubTator, text mining | PubMed |
| Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer. | Cells | 2022 | 35326424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=46